Overview
- 3 FDA inspections are on record.
- 3 inspections produced a Form 483.
- The most recent recorded inspection date is 2023-08-25.
At a glance
Inspections
3
Form 483s
3
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 10 Jul 2023 – 25 Aug 2023 | Human Drugs | WL | View 483 → |
| 27 Aug 2018 – 11 Sep 2018 | Human Drugs | 483 | View 483 → |
| 4 Aug 2014 – 8 Aug 2014 | Human Drugs | WL | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
25 Aug 2023
21 CFR 211.100(a)
Absence of Written Procedures
Cited by Xiaohui Shen, Jolanna A Norton, Doan N Singh, Rachel C Stanton
25 Aug 2023
21 CFR 211.100(b)
SOPs not followed / documented
Cited by Xiaohui Shen, Jolanna A Norton, Doan N Singh, Rachel C Stanton
25 Aug 2023
21 CFR 211.113(b)
Procedures for sterile drug products
Cited by Xiaohui Shen, Jolanna A Norton, Doan N Singh, Rachel C Stanton
25 Aug 2023
21 CFR 211.160(a)
Following/documenting laboratory controls
Cited by Xiaohui Shen, Jolanna A Norton, Doan N Singh, Rachel C Stanton
25 Aug 2023
21 CFR 211.160(b)
Scientifically sound laboratory controls
Cited by Xiaohui Shen, Jolanna A Norton, Doan N Singh, Rachel C Stanton
Investigators
FDA investigators tied to this site in the record.
Xiaohui Shen1 insp.
Jolanna A Norton1 insp.
Doan N Singh1 insp.
Rachel C Stanton1 insp.
Joey V Quitania1 insp.
Scott T Ballard1 insp.
Binh T Nguyen1 insp.
Andrew J Brown1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.42(c)(10)(iv) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.165(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.125(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.167(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.186(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.198(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.28(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(v) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(vi) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.56(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.80(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Central Admixture Pharmacy Services Inc's 3 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat